Merck · 21 hours ago
Associate Scientist, Cell-Based Assays
Merck is a leading company in drug discovery, and they are seeking a driven Research Associate to join their dynamic lab team. The role involves developing and executing complex cell-based assays while working collaboratively in a lab environment to contribute to therapeutic breakthroughs.
Responsibilities
Assist in developing, executing, and troubleshooting new cell-based assays, protocols, and analysis methods
Establish SOPs using automation (BRAVO/Apricot) to increase assay throughput
Design and execute experiments, interpret data, and communicate results and findings clearly and concisely to teams and stakeholders
Support the maintenance and characterization of iPSC-derived cell populations including immunocytochemistry, plate-based assays (Quanterix, Luminex, MSD), qPCR and other molecular biology techniques
Collaborate across functional areas
Qualification
Required
BS degree in molecular and cell biology or related disciplines such as immunology or biological engineering with 1-2+ years of wet lab experience in academia or industry
Extensive experience with mammalian cell culture using sterile techniques
Demonstrated ability to perform accurate data analysis and carefully maintain a notebook record of lab activities
Excellent oral and written communication skills, including preparation of lab reports and presentations
Strong attention to detail
Extensive in vitro experience
Successful candidate must be able to remain focused and on task without supervision
Work Environment: This is a 100% onsite, in-lab role; candidates must be comfortable working in a physical laboratory setting daily
Soft Skills: The successful candidate must be self-motivated, able to remain focused on tasks without constant supervision, and possess excellent written and oral communication skills
Company
Merck
Merck is a biopharmaceutical company that offers medicines and vaccines for various diseases.
Funding
Current Stage
Public CompanyTotal Funding
$5.59MKey Investors
Private Capital AdvisorsGavi, the Vaccine Alliance
2018-11-25Post Ipo Equity· $0.59M
2016-01-21Series Unknown· $5M
1980-12-19IPO
Leadership Team
Recent News
Company data provided by crunchbase